Wed October 19th, 2016
The Global Western Blotting Market is broadly categorized into disease diagnosis, agriculture, biochemical and biomedical research.
Download PDF for Explore in Depth of this Market@ http://tinyurl.com/h9e5jo3 The global western blotting market is segmented on the basis of products, applications, end users, and geographies. Based on products, the global market includes instruments and consumables. Instruments are further classified into manual systems, semi-automated systems, and automated systems. The consumables segment is divided into kits, reagents, and others. The reagents are further classified as chromogenic reagents, chemiluminescent reagents, fluorescent reagents, Chemifluorescent reagents and radioisotopic reagents. The others segment includes membranes, blotting papers, and molecular markers. Based on applications, the global western blotting market is broadly categorized into disease diagnosis, agriculture, biochemical and biomedical research, and others. Based on geography, the market is divided into North America, Europe, Asia, and the Rest of World (ROW). The market by end users is segmented into pharmaceuticals and biotechnology companies, academic and research institutes, and diagnostic laboratories. A number of factors such as automation in western blotting workstations, global increase in the life science R&D spending, growing proteomics market, rising prevalence of HIV, and companies focusing on validating the antibodies propel the growth of the market. However, high costs of primary antibodies and the emergence of alternative technologies are the major factors hindering the growth of this market. The major players in the global western blotting market include Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), GE Healthcare (U.K.), Merck Millipore (U.S.), Sigma-Aldrich Corporation (U.S),PerkinElmer, Inc. (U.S.), Roche Applied Science(U.S), ProteinSimple, Inc. (U.S.), LI-COR Biosciences (U.S.), and Advansta, Inc. (U.S.).